# FDA Inspection 1240356 - ImpactLife - May 30, 2024

Source: https://www.keypedia.com/records/fda_inspections/impactlife/91a3ca91-b0b2-46e7-bce1-b3e5ec4f3f43
Source feed: FDA_Inspections

> FDA Inspection 1240356 for ImpactLife on May 30, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240356
- Company Name: ImpactLife
- Inspection Date: 2024-05-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1114603 - 2019-12-19](https://www.keypedia.com/records/fda_inspections/impactlife/c2784b3f-c288-404d-ba1c-b3bcc001cc04)
- [FDA Inspection 1030109 - 2017-10-06](https://www.keypedia.com/records/fda_inspections/impactlife/70a0b0b7-7c21-4f02-b7a1-351e91850635)
- [FDA Inspection 1030109 - 2017-10-06](https://www.keypedia.com/records/fda_inspections/impactlife/2e89faca-7ddf-4af9-8025-43793503b1ff)
- [FDA Inspection 948008 - 2015-10-09](https://www.keypedia.com/records/fda_inspections/impactlife/58826398-8b23-411c-9d36-ce2f047c77e3)
- [FDA Inspection 854420 - 2013-11-05](https://www.keypedia.com/records/fda_inspections/impactlife/aae4ab6d-8c74-432a-8868-25ecc54cc52e)

Company: https://www.keypedia.com/companies/impactlife/c495b13d-4233-4d21-b530-4e1df39ce388

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d